Press release
Global mRNA Vaccines & Therapeutics Sales Market Report 2018
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
mRNA Vaccines & Therapeutics is in the development stage and there is no use in the market. The fastest research is Clinical phrase II, such as AGS-004 of Argos Therapeutics, SB-FIX, SB-318, SB-913 of Sangamo Therapeutics. The major application of mRNA Vaccines & Therapeutics is for infectious disease, cancer and others. And infectious disease and cancer are the major applications.
Request Sample Copy of Report@ https://www.qyresearch.com/sample-form/form/131231/global-mrna-vaccines-therapeutics-sales-market
Since the product still in development stage, so companies rely mainly on investment or cooperation to obtain funding to continue research and development.
The research of mRNA Vaccines & Therapeutics to treat infectious disease, cancer and others. The expenses on infectious disease is the most, with the market share of 46% in 2017.
The major players covered in this report
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
Request to Buy Full Report@ https://www.qyresearch.com/settlement/pre/805cbe3b0b66e19cd3b7882a35665528,0,1
eTheRNA
Ethris
Tiba Biotechnology
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India
We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Standardization Of Cancer Treatment MRNA Vaccine
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Infectious Disease
Cancer
Other
Ask for Discount on Research Report@ https://www.qyresearch.com/request-discount/form/131231/global-mrna-vaccines-therapeutics-sales-market
About Us:
QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert’s resources (included energy automotive chemical medical ICT consumer goods etc.
Contact US
QY Research, INC.
17890 Castleton, Suite 218,
City of industry, CA – 91748
USA: +1 6262 952 442
China: +86 1082 945 717
Japan: +81 9038 009 273
India: +91 9766 478 224
Emails – enquiry@qyresearch.com
Web – www.qyresearch.com
Expert News: www.qyresearch.com/expert/list
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global mRNA Vaccines & Therapeutics Sales Market Report 2018 here
News-ID: 1225736 • Views: …
More Releases from QY Research, INC.
Through Glass Via (TGV) Interposers Market to Reach US$ 319 Million by 2031, Acc …
Market Summary -
The global market for Through Glass Via (TGV) Interposers was estimated to be worth US$ 101 million in 2024 and is forecast to reach a readjusted size of US$ 319 million by 2031, expanding at a robust CAGR of 18.0% during the forecast period 2025-2031.
According to QY Research, the newly released report titled "Through Glass Via (TGV) Interposers Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031"…
Epinephrine Hydrochloride Injection Market to Reach US$ 5.59 Billion by 2031, Dr …
Market Summary -
The global market for Epinephrine Hydrochloride Injection was estimated to be worth US$ 4,025 million in 2024 and is forecast to reach a readjusted size of US$ 5,592 million by 2031, expanding at a steady CAGR of 4.8% during the forecast period 2025-2031.
According to QY Research, the newly released report titled "Epinephrine Hydrochloride Injection Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031" provides a comprehensive, data-driven…
Brushless Drone Motor Market to Reach US$ 3.11 Billion by 2031, Driven by Rapid …
Market Summary -
The global market for Brushless Drone Motor was estimated to be worth US$ 1,074 million in 2024 and is forecast to reach a readjusted size of US$ 3,105 million by 2031, expanding at a strong CAGR of 16.7% during the forecast period 2025-2031.
According to QY Research, the newly released report titled "Brushless Drone Motor Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031" provides a comprehensive, data-driven…
Semiconductor Underfill Market to Reach US$ 1.45 Billion by 2031, Driven by Adva …
Market Summary -
The global market for Semiconductor Underfill was estimated to be worth US$ 721 million in 2024 and is forecast to reach a readjusted size of US$ 1,445 million by 2031, expanding at a robust CAGR of 10.5% during the forecast period 2025-2031.
According to QY Research, the newly released report titled "Semiconductor Underfill Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031" provides a comprehensive, data-driven assessment of…
More Releases for Therapeutics
Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years.
DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Some of the…
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years.
DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,…
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611
Focused on growth…
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan.
Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Hodgkin's…
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space.
Key Takeaways from…
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…
